V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002174 | 230004625 | null | null | null | null | 2018-08-02 | PACLITAXEL | 02 | null | PACLITAXEL | 100403577 |
| 230002175 | 230004626 | 1.67 | 81.6 | null | 2019-03-07 | 2019-03-28 | Bevacizumab 7.5mg/kg | null | null | CARBOPLATIN | 101321904 |
| 230002176 | 230004627 | 1.48 | 39 | null | 2019-08-18 | 2019-08-25 | Bevacizumab | 02 | null | BEVACIZUMAB | 100283370 |
| 230002177 | 230004628 | 1.65 | 75.9 | Curative (C) | 2020-02-20 | 2020-02-22 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101007442 |
| 230002178 | 230004629 | 1.62 | 53.9 | null | null | 2021-05-05 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100151336 |
| 230002179 | 230004630 | 1.64 | 50 | null | 2017-02-27 | 2017-08-16 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100556662 |
| 230002182 | 230004633 | null | null | Palliative (P) | null | 2019-11-01 | ETOPOSIDE | 02 | N | FLUOROURACIL + OXALIPLATIN | 101006413 |
| 230002184 | 230004635 | null | null | null | 2019-12-25 | 2020-01-06 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100731831 |
| 230002187 | 230004638 | 1.61 | 101 | null | 2018-03-21 | 2018-11-14 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100767357 |
| 230002188 | 230004639 | 1.64 | 72.7 | Adjuvant (A) | null | 2016-04-13 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100443463 |
| 230002189 | 230004640 | 1.58 | 75 | null | null | 2019-12-03 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 101550128 |
| 230002192 | 230004643 | null | null | null | null | 2018-11-01 | CYCLOPHOSPHAMIDE + DOCETAXEL + DOXORUBICIN + TRASTUZUMAB | 02 | null | ICON8B TRIAL | 101733010 |
| 230002193 | 230004644 | 1.59 | 61 | null | 2021-09-20 | 2021-09-20 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100645564 |
| 230002195 | 230004646 | 1.58 | 47.1 | Palliative (P) | 2019-10-02 | 2019-10-14 | null | 02 | N | NIVOLUMAB | 100225814 |
| 230002196 | 230004647 | 1.65 | 58 | Neo-adjuvant (N) | 2019-07-07 | 2019-08-11 | null | 02 | N | ICON TRIAL | 100917034 |
| 230002197 | 230004648 | null | null | null | 2017-09-19 | 2017-09-22 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | ICON8B TRIAL | 100121097 |
| 230002201 | 230004652 | 1.56 | 93 | null | 2019-03-08 | 2019-03-13 | null | 02 | null | PEMBROLIZUMAB | 100007241 |
| 230002204 | 230004654 | 1.64 | 51.8 | null | null | 2017-01-27 | null | N | null | OLAPARIB | 100481539 |
| 230002205 | 230004655 | null | null | null | 2019-06-20 | 2019-06-21 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101863147 |
| 230002206 | 230004656 | 1.55 | 89.5 | null | 2020-09-08 | 2020-10-13 | Niraparib | 02 | null | NIRAPARIB | 101293099 |
| 230002207 | 230004657 | null | null | null | null | 2020-08-14 | Cisplatin | 02 | null | GEMCITABINE | 100544319 |
| 230002208 | 230004658 | 1.59 | 87 | Palliative (P) | 2020-11-16 | 2021-01-19 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100417143 |
| 230002209 | 230004659 | 1.6 | 139.5 | null | 2017-03-15 | 2017-09-16 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100665086 |
| 230002210 | 230004660 | 1.56 | 98.8 | Neo-adjuvant (N) | null | 2019-03-22 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100975773 |
| 230002211 | 230004661 | 1.55 | 68 | null | null | 2018-05-30 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101395853 |
| 230002213 | 230004663 | 1.6 | 44.3 | null | 2020-07-31 | 2020-07-31 | null | 02 | null | PEMBROLIZUMAB | 100396177 |
| 230002215 | 230004665 | 1.7 | 104.4 | null | 2021-01-04 | 2021-01-23 | Olaparib | 02 | null | OLAPARIB | 100115300 |
| 230002217 | 230004667 | 1.61 | 61 | null | null | 2019-03-07 | null | null | null | RUCAPARIB | 101241691 |
| 230002223 | 230004673 | 1.66 | 108 | null | null | 2021-08-04 | null | null | N | PACLITAXEL | 101466493 |
| 230002224 | 230004674 | null | null | null | 2022-04-20 | 2022-04-23 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101031287 |
| 230002225 | 230004675 | null | null | null | 2018-04-02 | 2018-04-15 | Olaparib | 02 | null | OLAPARIB | 101600305 |
| 230002226 | 230004676 | 1.66 | 51.5 | null | 2020-08-29 | 2020-08-29 | null | null | null | PACLITAXEL | 100126004 |
| 230002230 | 230004679 | 1.66 | 118 | null | 2021-01-18 | 2021-01-25 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100682958 |
| 230002231 | 230004680 | 1.61 | 58.6 | null | 2019-08-31 | 2019-08-31 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100733877 |
| 230002233 | 230004682 | 1.69 | 57 | Adjuvant (A) | null | 2017-08-27 | null | 02 | N | PEMBROLIZUMAB | 101079093 |
| 230002234 | 230004683 | 1.55 | 80 | null | 2018-12-31 | 2019-07-05 | null | null | null | OLAPARIB | 101273499 |
| 230002236 | 230004684 | 1.74 | 59.2 | Palliative (P) | 2017-10-28 | 2017-10-28 | PACLITAXEL | 02 | N | PACLITAXEL | 100590159 |
| 230002237 | 230004685 | null | null | Palliative (P) | 2019-05-02 | 2019-05-26 | Niraparib | 02 | N | NIRAPARIB | 100107581 |
| 230002239 | 230004687 | null | null | null | 2014-09-30 | 2016-06-04 | Olaparib | 02 | null | OLAPARIB | 101256331 |
| 230002241 | 230004689 | 1.59 | 86.2 | null | 2017-07-05 | 2017-07-08 | null | 02 | null | HYDROXYCARBAMIDE | 101828377 |
| 230002242 | 230004690 | 1.67 | 51.1 | null | null | 2017-09-07 | Olaparib | 02 | null | OLAPARIB | 100029086 |
| 230002243 | 230004691 | 1.64 | 156.1 | Adjuvant (A) | 2017-05-14 | 2017-05-15 | null | null | N | ICON9 TRIAL | 100935196 |
| 230002245 | 230004693 | null | null | Curative (C) | 2017-06-09 | 2017-06-11 | null | null | N | PACLITAXEL | 100358109 |
| 230002246 | 230004694 | 1.62 | 104.4 | Palliative (P) | null | 2019-10-20 | null | null | N | OLAPARIB | 100259364 |
| 230002249 | 230004697 | 1.52 | null | null | 2019-07-13 | 2019-07-16 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100444839 |
| 230002252 | 230004700 | 1.67 | 105.3 | null | 2019-12-12 | 2019-12-25 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101589084 |
| 230002254 | 230004702 | 1.57 | 111 | Palliative (P) | null | 2019-10-05 | null | null | null | PACLITAXEL | 100931203 |
| 230002257 | 230004705 | 1.52 | 41.1 | null | 2018-10-20 | 2019-03-21 | null | null | null | BEVACIZUMAB | 100731899 |
| 230002258 | 230004706 | 1.51 | 50.1 | null | 2019-03-18 | 2019-04-08 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100778972 |
| 230002260 | 230004708 | null | null | null | 2016-07-31 | 2016-08-05 | Olaparib | 02 | null | OLAPARIB | 101429567 |